Peer-reviewed veterinary case report
High-flow nasal oxygen therapy for dogs hospitalized with pneumonia
By Teppo, Anna-Maija et al.·Published in BMC veterinary research·2023·Department of Equine and Small Animal Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Proposed protocol for utilising high-flow nasal oxygen therapy in treatment of dogs hospitalised due to pneumonia.
- Species:
- dog
Plain-English summary
A group of dogs with pneumonia were treated with a new method called high-flow nasal oxygen therapy, which delivers warm, humidified oxygen to help them breathe better. This therapy is non-invasive and was given to 20 dogs in a veterinary hospital, with adjustments made to the oxygen levels based on each dog's needs. The goal was to see if this method could improve their oxygen levels and overall recovery compared to traditional treatments. The results suggest that high-flow nasal oxygen could be a safe and effective way to support dogs with pneumonia, helping them recover faster and potentially improving their chances of survival.
People also search for: dog pneumonia treatment · high-flow nasal oxygen for dogs · how to help my dog breathe better · dog respiratory support options
Abstract
BACKGROUND: High-flow nasal oxygen (HFNO) therapy is a non-invasive respiratory support method that provides oxygen-enriched, warmed, and humidified air to respiratory-compromised patients. It is widely used in human medical care, but in veterinary medicine it is still a relatively new method. No practical guidelines exist for its use in canine pneumonia patients, although they could potentially benefit from HFNO therapy. This study aims to provide a new, safe, non-invasive, and effective treatment protocol for oxygen supplementation of non-sedated dogs with pneumonia. METHODS: Twenty privately owned dogs with pneumonia will receive HFNO therapy at a flow rate of 1-2 L/kg, and the fraction of inspired oxygen will be determined individually (ranging from 21% to 100%). HFNO therapy will continue as long as oxygen support is needed based on clinical evaluation. Patients will be assessed thrice daily during their hospitalisation, with measured primary outcomes including partial pressure of oxygen, oxygen saturation, respiratory rate and type, days in hospital, and survival to discharge. DISCUSSION: The proposed protocol aims to provide a practical guideline for applying HFNO to dogs hospitalised due to pneumonia. The protocol could enable more efficient and well-tolerated oxygenation than traditional methods, thus hastening recovery and improving survival of pneumonia patients.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/37735404/